StockData
MDxHealth SA logo

MDxHealth SA (MDXH) stock

MDXHNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 3, 2026Score 5/30
$0.14−0.01 (-5.97%)

Close on Nov 18, 2026Market cap $719.62KP/E –Yield –

MDxHealth r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $10.35M, down 1.9% from the year before. The highest annual figure on record is $10.55M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.35M-1.9%
FY2024Dec 31, 2024$10.55M+65.5%
FY2023Dec 31, 2023$6.38M+16.0%
FY2022Dec 31, 2022$5.50M-1.6%
FY2021Dec 31, 2021$5.59M+23.0%
FY2020Dec 31, 2020$4.54M-49.5%
FY2019Dec 31, 2019$9.00M–

More MDxHealth figures

See a number that looks wrong?